Join
Live feed
·
PRReleasevia Quantisnow
Adicet Bio Inc. logo

Adicet Bio Announces Completion of Last Patient Visit for Planned Analysis of prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus With or Without Lupus Nephritis and Provides Corporate Update

ByQuantisnow·Wall Street's wire, on your screen.
ACET· Adicet Bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACET (Adicet Bio Inc.) and more on Quantisnow.